Results 71 to 80 of about 648,549 (288)

Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2 [PDF]

, 2020
Background and purpose Infections with coronaviruses are not always confined to the respiratory tract and various neurological manifestations have been reported.
Boon, Paul, De Herdt, Veerle, Garrez, Ieme, Hemelsoet, Dimitri, Laureys, Guy, Raedt, Robrecht, Vonck, Kristl   +6 more
core   +2 more sources

Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19)

Clinical and experimental pediatrics, 2020
A cluster of severe pneumonia of unknown etiology in Wuhan City, Hubei province in China emerged in December 2019. A novel coronavirus named severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was isolated from lower respiratory tract sample as ...
Su Eun Park
semanticscholar   +1 more source

Severe acute respiratory syndrome coronavirus-2 Alpha variant (B.1.1.7), original wild-type severe acute respiratory syndrome coronavirus 2, and cytomegalovirus co-infection in a young adult with acute lymphoblastic leukemia, case report, and review of the possible cytomegalovirus reactivation mechanisms

Journal of Medical Case Reports, 2023
Background Like other viral infections, severe acute respiratory syndrome coronavirus-2 infection could affect different human body systems, including host immune responses. Three years after its pandemic, we learn more about this novel coronavirus.
Ali Amanati, Mahdi Shahriari, Mohammad Reza Bordbar, Seyyed Bozorgmehr Hedayati, Mazyar Ziyaeyan, Marzieh Jamalidoust, Mehdi Kalani, Nahid Heydari Marandi   +7 more
doaj   +1 more source

Governmental Public Health Powers During the COVID-19 Pandemic: Stay-at-home Orders, Business Closures, and Travel Restrictions [PDF]

, 2020
The president and all 50 governors have declared health emergencies to combat the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19). While researchers race for vaccines, officials are
Gostin, Lawrence O., Wiley, Lindsay F.
core   +2 more sources

Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

JAMA Network Open, 2020
Key Points Question How safe and effective are 2 different regimens of chloroquine diphosphate in the treatment of severe coronavirus disease 2019 (COVID-19)? Findings In this phase IIb randomized clinical trial of 81 patients with COVID-19, an unplanned
M. Borba, F. Val, V. Sampaio, M. Alexandre, G. Melo, Marcelo Brito, M. P. Mourão, J. Brito-Sousa, D. Baía-da-Silva, M. V. Guerra, L. Hajjar, R. Pinto, A. Balieiro, A. G. Pacheco, James D. Santos, F. Naveca, M. Xavier, André M. Siqueira, A. Schwarzbold, Júlio Croda, M. Nogueira, G. Romero, Quique Bassat, C. Fontes, B. Albuquerque, C. Daniel-Ribeiro, W. Monteiro, M. Lacerda   +27 more
semanticscholar   +1 more source

Binding and entering: COVID finds a new home.

PLoS Pathogens, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) emerged as a virus with a pathogenicity closer to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and a transmissibility ...
Michelle N Vu, Vineet D Menachery
doaj   +1 more source

The Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Directly Decimates Human Spleens and Lymph Nodes

medRxiv, 2020
While lymphocytopenia is a common characteristic of patients infected by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the mechanisms responsible for this depletion are unclear.
Yongwen Chen, Zeqing Feng, B. Diao, Rongshuai Wang, Gang Wang, Chenhui Wang, Yi-ran Tan, Liang Liu, Changsong Wang, Ying Liu, Yueping Liu, Zilin Yuan, L. Ren, Yuzhang Wu   +13 more
semanticscholar   +1 more source

COVID-19 Infection: Implications for Perioperative and Critical Care Physicians. [PDF]

, 2020
Healthcare systems worldwide are responding to Coronavirus Disease 2019 (COVID-19), an emerging infectious syndrome caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus. Patients with COVID-19 can progress from asymptomatic or
Greenland, John R, London, Martin J, Michelow, Marilyn D, Wang, Linlin   +3 more
core  

First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA

The Lancet, 2020
Background Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first detected in China in December, 2019. In January, 2020, state, local, and federal public health agencies investigated
Isaac Ghinai, Tristan D. McPherson, J. Hunter, H. Kirking, Illinois COVID-19 Investigation Team   +4 more
semanticscholar   +1 more source

Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection

Clinical Microbiology Reviews, 2021
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory disease coronavirus 2 (SARS-CoV-2), has led to millions of confirmed cases and deaths worldwide.
Seyed Hamid Safiabadi Tali, J. LeBlanc, Zubi Sadiq, Oyejide Damilola Oyewunmi, C. Camargo, Bahareh Nikpour, N. Armanfard, S. Sagan, Sana Jahanshahi-Anbuhi   +8 more
semanticscholar   +1 more source